Nuclear Receptor Subfamily 4A Signaling as a Key Disease Pathway of CD1c+ Dendritic Cell Dysregulation in Systemic Sclerosis.

NR4A2 ( P = 0.002) and NR4A3 ( P = 0.035) were significantly down‐regulated in the dcSSc patient group (Figure 3B ), and NR4A1 showed a nonsignificant trend ( P = 0.18) for down‐regulation (Figure 3B ).

also in 5,406 other papers